Patel Gautam
SEC CIK 1738054 · EDGAR
BoughtSold
Most active insiders at AMRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shah Nikita | EVP | — | $4.14M |
| 2 | Daly Jason B. | EVP, CLO | — | $3.77M |
| 3 | Kiely John | Dir | — | $882.0K |
| 4 | Nark Ted C | Dir | — | $586.0K |
| 5 | Autor Deborah M. | Dir | — | $450.6K |
| 6 | George Jeffrey P. | Dir | — | — |
| 7 | Patel Tushar Bhikhubhai | 10% | — | — |
| 8 | Patel Chirag K. | Pres, Co-CEO, Dir | — | — |
| 9 | Patel Gautam | Dir | — | — |
| 10 | Patel Chintu | Co-CEO, Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-12 16:39 | 2026-08-10 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | A - Grant | — | +283.6K | 283.6K | New | — |
| D | 2026-05-08 16:26 | 2026-05-07 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | M - OptEx | — | +34.8K | 1.64M | +2% | — |
| 2025-12-16 | 2025-12-12 | SPB | Spectrum Brands Holdings, Inc. | Patel Gautam | Dir | A - Grant | $0.00 | +4,602 | 22.1K | +26% | $0 | |
| 2025-06-18 | 2025-06-16 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | S - Sale | $8.02 | -94.9K | 1.61M | -6% | -$761.1K | |
| 2025-06-12 | 2025-06-10 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | S - Sale | $8.02 | -56.4K | 1.70M | -3% | -$452.5K | |
| D | 2025-05-08 | 2025-05-05 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | M - OptEx | — | +40.3K | 1.76M | +2% | — |
| M | 2025-05-06 | 2025-05-02+ | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | S - Sale | $8.00 | -8,668 | 1.72M | -0.5% | -$69.3K |
| 2025-04-02 | 2025-04-01 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | S - Sale | $8.30 | -80.0K | 1.73M | -4% | -$664.0K | |
| 2025-03-05 | 2025-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | S - Sale | $8.90 | -80.0K | 1.81M | -4% | -$712.0K | |
| 2025-02-05 | 2025-02-03 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | S - Sale | $8.14 | -80.0K | 1.89M | -4% | -$651.2K | |
| 2025-01-10 | 2025-01-08 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | S - Sale | $8.01 | -62.6K | 1.97M | -3% | -$501.3K | |
| 2025-01-06 | 2025-01-02 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | S - Sale | $8.01 | -17.4K | 2.03M | -0.8% | -$139.5K | |
| 2024-11-20 | 2024-11-19 | SPB | Spectrum Brands Holdings, Inc. | Patel Gautam | Dir | A - Grant | $90.26 | +2,770 | 17.5K | +19% | +$250.0K | |
| D | 2024-05-14 | 2024-05-10 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | M - OptEx | — | +76.5K | 2.05M | +4% | — |
| 2024-01-03 | 2024-01-01 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | G - Gift | $0.00 | +1.60M | 1.97M | +427% | $0 | |
| 2024-01-03 | 2024-01-01 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | J - Other | — | -33.46M | 374.3K | -99% | — | |
| AI | 2023-12-01 | 2021-12-01 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir, 10% | J - Other | — | +3.07M | 15.96M | +24% | — |
| 2023-11-28 | 2023-11-24 | SPB | Spectrum Brands Holdings, Inc. | Patel Gautam | Dir | A - Grant | $0.00 | +3,775 | 14.8K | +34% | $0 | |
| DI | 2023-11-08 | 2023-11-07 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir, 10% | J - Other | — | +17.50M | 30.38M | +136% | — |
| D | 2023-05-11 | 2023-05-10 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | M - OptEx | — | +80.1K | 374.3K | +27% | — |
| 2022-11-29 | 2022-11-25 | SPB | Spectrum Brands Holdings, Inc. | Patel Gautam | Dir | A - Grant | $0.00 | +5,020 | 11.0K | +84% | $0 | |
| D | 2022-05-10 | 2022-05-08 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | M - OptEx | — | +35.4K | 294.2K | +14% | — |
| 2021-12-20 | 2021-12-17 | AMRX | Amneal Pharmaceuticals, Inc. | Patel Gautam | Dir | P - Purchase | $4.21 | +50.0K | 258.8K | +24% | +$210.5K | |
| 2021-12-17 | 2021-12-15 | SPB | Spectrum Brands Holdings, Inc. | Patel Gautam | Dir | A - Grant | $0.00 | +2,441 | 5,974 | +69% | $0 |
Purchase Sale Sale after option exercise All abbreviations